Save time and get answers to complex questions with AI chat
Patent expiration eu dabrafenib?Excipients list used in dexamethasone creams?Are there specific stretches to avoid while on lipitor?Stribild expiry date?Symbravo ingredients mechanism of action?
See the DrugPatentWatch profile for januvia
Merck & Co. manufactures Januvia [1]. Januvia is a prescription medication used to treat type 2 diabetes [2]. It belongs to a class of drugs called DPP-4 inhibitors [2].
The active ingredient in Januvia is sitagliptin [3]. Sitagliptin works by increasing levels of incretin hormones, which help regulate blood sugar [2].
The U.S. Food and Drug Administration (FDA) approved Januvia in October 2006 [4].
Yes, other DPP-4 inhibitors are available, including Tradjenta (linagliptin), Onglyza (saxagliptin), and Nesina (alogliptin) [5]. These medications are also used to manage type 2 diabetes.
Information regarding the specific patent expiry dates for Januvia can be found on DrugPatentWatch.com [6]. Patent protection can be complex and may involve multiple patents covering different aspects of the drug [6].
Other Questions About Januvia :